Elizabethkingia anophelis Infection in Infants, Cambodia, 2012-2018

Emerg Infect Dis. 2020 Feb;26(2):320-322. doi: 10.3201/eid2602.190345.

Abstract

We describe 6 clinical isolates of Elizabethkingia anophelis from a pediatric referral hospital in Cambodia, along with 1 isolate reported from Thailand. Improving diagnostic microbiological methods in resource-limited settings will increase the frequency of reporting for this pathogen. Consensus on therapeutic options is needed, especially for resource-limited settings.

Keywords: Cambodia; Elizabethkingia anophelis; Laos; Thailand; antimicrobial resistance; bacteria; neonatal sepsis.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia / diagnosis*
  • Bacteremia / drug therapy
  • Ciprofloxacin / pharmacology
  • Ciprofloxacin / therapeutic use
  • Female
  • Flavobacteriaceae / drug effects
  • Flavobacteriaceae / genetics
  • Flavobacteriaceae / isolation & purification*
  • Flavobacteriaceae Infections / diagnosis*
  • Flavobacteriaceae Infections / drug therapy
  • Humans
  • Infant, Newborn
  • Microbial Sensitivity Tests
  • Vancomycin / pharmacology
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • Vancomycin

Supplementary concepts

  • Elizabethkingia anophelis